Compare · 2 funds side by side · dividends reinvested

CURE and SPYM

CUREDirexion×SPYMSPDR×

Versus in desk

Story of the two · Growth5Y$10,000 five years agoDividends reinvested · both on one scale$17,192SPYM · best of the two

02 / 04

CURE and SPYM, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

State Street SPDR Portfolio S&P 500 ETFLow-Cost Core · S&P 5000.02%1.05%+8.8%+9.8%+21.8%+11.4%−8.9%13.6%$182B1.4

Direxion Daily Healthcare Bull 3X ETFLeveraged · 3x0.94%0.76%+50.3%+78.2%+29.6%+7.3%−31.1%49.4%$217M1.6

Rank among the two1st → 2ndFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 6, 2026 · returns include dividends · since: CURE 2011 · SPYM 2005

Head to Head

Swap sides Versus in desk

Head to Head

Direxion Daily Healthcare Bull 3X ETF · $217M$14,199

CURE

SPYM

State Street SPDR Portfolio S&P 500 ETF · $182B$17,192

$10,000 five years ago, dividends reinvested · they hold 10.6% in common

CUREMeasureSPYM

+50.3%Year to dateJan 1 → Nov 6+8.8%

+78.2%1 yearTotal return+9.8%

+29.6%3 years · per year$10,000 became $21,743 · $18,082+21.8%

+7.3%5 years · per year$10,000 became $14,199 · $17,192+11.4%

0.94%Expense ratio$94 · $2 a year on $10k · lower is better0.02%

0.76%Trailing 12-mo yield$76 · $105 a year on $10k1.05%

−31.1%Worst dropSmaller is better−8.9%

49.4%VolatilityLower is calmer13.6%

CURESPYM Winner of the row, in its colourEach row: the bigger of the two fills its side

3–5SPYM wins

End-of-day Nov 6, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

More Ways to See the Pairs

CURE vs SPYM: Top 5 Holdings

Today

CURE

9.1%in top 5

SPYM

in top 527.8%

CUREStockSPYM

not top 5AAPL7.9%

not top 5NVDA6.9%

not top 5MSFT6.3%

not top 5AMZN4.0%

3.3%LLYnot top 5

not top 5GOOGL2.6%

2.0%JNJnot top 5

1.6%ABBVnot top 5

1.1%MRKnot top 5

1.1%UNHnot top 5

Held in common10.6%

End-of-day Nov 6, 2026 · share of each fund

CURE vs SPYM Returns, Every Period

DirexionCURE

+7.3%

5 years, per year

SPYMSPDR

+11.4%

5 years, per year

CURESPYMFaded: behind in that period

3–1CURE wins

End-of-day Nov 6, 2026 · dividends in · faded = behind in that period

Leveraged vs Core: CURE vs SPYM

YTD

DirexionCURE

+50.3%

SPYMSPDR

+8.8%

+50.3%Year to date+8.8%

−31.1%Worst drop · 1Y−8.9%

49.4%Volatility · 1Y13.6%

0.8%Yield1.1%

$217MAssets$182B

3–1SPYM wins

End-of-day Nov 6, 2026 · smaller drop and lower volatility win

Cost, Income and Risk

Fees: CURE, SPYM

Today

0.02%lowest, SPYM

FundExpense ratioFee$10k

SPYM0.02%$2

CURE0.94%$94

End-of-day Nov 6, 2026 · fee on $10,000 a year

Yields: CURE, SPYM

1.05%highest, SPYM

FundTrailing yieldYield$10k

SPYM1.05%$105

CURE0.76%$76

End-of-day Nov 6, 2026 · trailing 12-month yield

Income After Fees on $10,000

$103most kept, SPYM

SPYM$105 − $2 = $103

CURE$76 − $94 = −$18

KeptFee

End-of-day Nov 6, 2026 · yield in dollars minus the fee

Overlap: CURE, SPYM

Today

10.6%most shared, CURE and SPYM

CURESPYM

CURE—10.6%

SPYM10.6%—

End-of-day Nov 6, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 2 ETFs

+78.2%CURE, at 49.4% volatility

SPYMWorst drop−8.9%13.6% vol

CUREWorst drop−31.1%49.4% vol

End-of-day Nov 6, 2026 · up and left is better

Paid More vs Made More

YTD

SPYMCURE

+8.8%Year to date+50.3%

1.1%Yield0.8%

+9.8%Past year+78.2%

0.02%Fee0.94%

2–2level

End-of-day Nov 6, 2026

Popular Pairs Near These Two

SPYM vs SPY

YTD

SPDRSPYM

+8.8%

SPYSPDR

+8.7%

+8.8%Year to date+8.7%

1.1%Yield1.0%

$182BAssets$819B

2–0SPYM wins

End-of-day Nov 6, 2026

SCHD vs VIG

YTD

SchwabSCHD

+31.4%

VIGVanguard

+12.1%

+31.4%Year to date+12.1%

3.0%Yield1.5%

$120BAssets$109B

2–0SCHD wins

End-of-day Nov 6, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+3.2%

JEPIJ.P. Morgan

+5.3%

+3.2%Year to date+5.3%

12.8%Yield8.1%

$42.6BAssets$46.8B

1–1level

End-of-day Nov 6, 2026